Michael A. Kutcher, MD, FACC, FSCAI

Renato M. Santos , MD;

Talal T. Baki , MD;

Frederic R. Kahl , MD;

William C. Little , MD;

Culprit Vessel PCI versus Traditional Cath and PCI for STEMI

Contrast-induced nephropathy (CIN) is a common problem after cardiac catheterization and percutaneous coronary intervention (PCI), and is associated with substantial morbidity and mortality.1–3 The etiology of CIN has not been clearly...

Contrast-induced nephropathy...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Stacy H. Graham , MD;

William C. Little , MD;

Renato M. Santos , MD;

Target Lesion Revascularization after Bare-Metal or Drug-Eluting Stents: Clinical Presentations and Outcomes

Achieving rapid reperfusion in patients with ST-elevation myocardial infarction (STEM) has been established as an effective and life-saving treatment for these patients. The mortality benefit of primary percutaneous coronary intervention...

Achieving rapid reperfusion in...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

06/02/2010

Renato M. Santos , MD;

Kevin R. Hayes , MD;

To PRAMI or not to PRAMI: Should we do PCI of the Non-Infarct-Related Artery in STEMI Patients?

William C. Little , MD;

ABSTRACT: Objective. We sought to examine the clinical presentations and subsequent clinical outcomes of patients undergoing target lesion revascularization (TLR) after either bare-metal stent (BMS) or drug-eluting stent (DES) placement....

ABSTRACT: Objective. We...

06/02/2010

Journal of Invasive Cardiology

Clinical Editor's Corner

01/07/2014

Gregg W. Stone , MD, FACC, FSCAI;

Highlights of the Scottsdale Interventional Forum 2014, How-to Symposiums: Advances in Chronic Total Occlusion Therapy

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Habib Samady , MD;

Justin E. Davies , MBBS, MRCP, PhD;

Peter Ver Lee , MD;

John Bittl , MD;

Samuel M. Butman , MD;

Lloyd W. Klein , MD;

My cardiology fellow said we should now stent the RCA since we were already here and the patient was quite stable. I demurred and said we will be back in a couple weeks unless the patient develops angina. The RCA could be treated after...

My cardiology fellow said we...

01/07/2014

Cath Lab Digest

02/01/2015

Boomer to Zoomer – Transforming to the Post-Pandemic World

Ashish Pershad , MD;

Mohamad Lazkani , MD;

David G. Rizik , MD, FACC, FSCAI;

Moneer Eddin , MD;

William L. Lombardi , MD;

The tenth annual Scottsdale Interventional Forum (SIF), which took place in Scottsdale, Arizona from March 5-8, 2014, brought together some of the leading experts in CTO-PCI. Topics discussed included review of the diagnostic coronary...

The tenth annual Scottsdale...

02/01/2015

Journal of Invasive Cardiology

Clinical Editor's Corner

07/06/2020

Barry F. Uretsky , MD;

Stephen R. Ramee , MD;

Peter C. Block , MD;

Frederic S. Resnic , MD, MSc;

Lloyd W. Klein , MD;

E. Magnus Ohman , MD;

Samuel M. Butman , MD;

Superior In-Hospital and 30-Day Outcomes with Abciximab Versus Eptifibatide: A Contemporary Analysis of 495 Consecutive Percutan

Jeffrey Marshall ;

Gary S. Mintz , MD;

Jonathan M. Tobis , MD;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

Chet Rihal ;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Carl L. Tommaso , MD;

Michael J. Lim , MD;

Larry S. Dean , MD, FACC, FAHA, FSCAI;

Christopher J. White , DO, MD;

Kirk N. Garratt , MD, MSc;

Jim Blankenship , MD;

Like many of my contemporaries, I am a boomer (aka baby boomer), a member of the post World War II generation. I grew up in the 1950-60s, graduated college in the Vietnam War era (1960-70s), and had a millennial-generation (1980-90s)...

Like many of my contemporaries,...

07/06/2020

Cath Lab Digest

08/01/2008

Vasoreactivity Testing and Chest Pain Guidelines: Is the IIa Recommendation Warranted? INOCA Part II

Bharathi Upadhya , MD;

David C. Sane , MD;

Efthymios N. Deliargyris , MD;

Over the past decade clinical trials have demonstrated that platelet glycoprotein (GP) IIb/IIIa receptor inhibition dramatically reduces the ischemic complications of percutaneous coronary intervention (PCI).1–6 Currently, there are 3...

Over the past decade clinical...

08/01/2008

Journal of Invasive Cardiology

Clinical Editor's Corner

09/05/2022

Lloyd W. Klein , MD;

Amir Lerman , MD;

Differences in Baseline Characteristics and In-hospital Outcomes in Patients with or without Prior Stroke Undergoing Percutaneou

Augusto D. Pichard , MD, FACC, FSCAI;

Samuel M. Butman , MD;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

Colin Berry , MBChB, BSc, PhD, MRCP;

Bernard DeBruyne ;

Gregory J. Dehmer , MD;

Spencer B. King III, MD;

Kreton Mavromatis , MD;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

David J. Moliterno , MD;

Srihari S. Naidu , MD;

Jonathan M. Tobis , MD;

Peter C. Block , MD;

Timothy D. Henry , MD;

Olga Toleva ;

INOCA and MINOCA (myocardial infarction with normal coronary arteries) are now widely known and gathering attention regarding their diagnosis and treatment. Many labs now have sensor guidewires and software to make this possible. Specialized...

INOCA and MINOCA (myocardial...

09/05/2022

Cath Lab Digest

08/01/2008

Bharathi Upadhya , MD;

David C. Sane , MD;

Efthymios N. Deliargyris , MD;

PCI with and without Abciximab after Upstream Eptifibatide Use: Outcomes in High-Risk Patients

Percutaneous coronary intervention (PCI) is increasingly used in patients with high-risk baseline characteristics.1–4 A prior stroke may identify patients who are at higher risk for post-PCI complications. However, no comparative data exist...

Percutaneous coronary...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Talal T. Baki , MD;

William C. Little , MD;